Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Our support includes tailored promotional materials such as visual merchandising, printed resources, and digital activations, all provided at no cost
PageMJMcKenzieJEBossuytPMBoutronIHoffmannTCMulrowCDet alUpdating guidance for reporting systematic reviews: Development of the PRISMA 2020 statement
The enzyme dechlorinates DCA to glyoxylate inactivating it (Fig
By Route of Administration (Daily Injectable, Weekly Injectable, and Oral Small-Molecule): The weekly injectable segment held a share of 90.80% in 2025, driven by convenience, improved patient adherence, and strong clinical outcomes
Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agents
PubMed PMID: 10734331
US$ 22.94
US$ 20.66
US$ 27.91
